Deadline

November 16, 2027

Budget

270.0M It’s possible that individual grant applications under this NOSI—such as R01 or R21 mechanisms—may be subject to standard NIH budget limits rather than a lump-sum allocation

Contact
deaweb@niaid.nih.gov
Funded by
NIAID

National Institute of Allergy and Infectious Diseases

us department of health and human services

U.S. Department of Health and Human Services (HHS).

Scope

The National Institute of Allergy and Infectious Diseases (NIAID) has issued a Notice of Special Interest (NOSI) to support innovative research advancing the development of a universal influenza vaccine. Priority areas include understanding influenza transmission, characterizing immune responses, and designing broadly protective vaccines. Projects may explore novel immunogens, delivery methods, and immune mechanisms across diverse populations.

Applications are accepted from February 5, 2025, through November 16, 2027, under NIH Parent R01 or R21 NOFOs. Applicants must reference “NOT-AI-24-081” in submissions.

Apply

(application receipt dates on or after February 5, 2025, and subsequent receipt dates through November 16, 2027)

Apply Here

Help build the STAR IDAZ community.
Share reports and updates on social channels.

More Funding Calls